Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs AT&T Inc. (T) Price & Performance

Abeona Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs AT&T Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 398.6× Abeona Therapeutics Inc's market cap, and AT&T Inc. pays a 4.53% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOT
Market Cap
$421.19M$167.88B
Sector
HealthMedia
52-Week High
$7.45$29.62
52-Week Low
$4.17$20.49
Enterprise Value
$276.10M$313.20B
Dividend Yield
4.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T